ADVANCE is the largest clinical trial on diabetes ever conducted
Over 11,000 patients are participating in the ADVANCE study
These patients have come from 20 different countries
ADVANCE also includes four major sub-studies, looking at heart and eye function after intervention, cost-effectiveness and quality of life, and genetic factors
Blood pressure results: the routine administration as a fixed combination of Perindopril and Indapamide (Preterax) improves survival and reduces coronary and renal events in diabetics